Clascoterone for Steroid-related Acne Vulgaris in Transgender Male Patients Receiving Masculinizing Hormone Therapy
Condition: Acne Vulgaris Interventions: Drug: Clascoterone 1% Top Cream; Drug: Vehicle Sponsor: Stanford University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 7, 2023 Category: Research Source Type: clinical trials
Focal Prostate Ablation With Androgen Deprivation and Novel Hormonal Therapy for Intermediate Risk Prostate Cancer
Condition: Prostate Cancer Interventions: Drug: Apalutamide Oral Product; Drug: Androgen Deprivation Therapy (ADT); Procedure: Focal Therapy Sponsors: University of Cincinnati; Janssen, LP Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 30, 2023 Category: Research Source Type: clinical trials